Skip to main content
. 2018 Feb 17;19(2):598. doi: 10.3390/ijms19020598

Figure 3.

Figure 3

Figure 3

HE-A, but not HE-S, reduces Aβ accumulation in APP/PS1 mice. APP/PS1 transgenic mice were orally administered with vehicle (Veh), HE-A or HE-S for 30 days (n = 8 for each group), and then the level of Aβ1−40 and Aβ1−42 in cortical homogenates was determined by enzyme-linked immunosorbent assay (ELISA) (A). The level of APP and C-terminal fragment (CTF) (B), and insulin-degrading enzyme (IDE) and neprilysin (NEP) (C) in homogenates were analyzed by immunoblotting. The level of IDE and NEP in wild type (WT) mice (n = 5) is also compared. Representative immunoblots are shown at the left panel. The ratio of CTF-α and −β to β-actin is presented as percentage of Veh group. The ratio of IDE to β-actin is presented as percentage of WT group. The results are the mean ± S.E.M. Significant differences between Veh group and the other groups are indicated by *, p < 0.05; **, p < 0.01.